<?xml version="1.0" encoding="UTF-8"?><mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd"><titleInfo><title>Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692)</title></titleInfo><name><namePart>Forey, F.</namePart></name><name><namePart>Tanghe, H.L.J. (Herv&#233;)</namePart></name><name><namePart>Niermeijer, M.F. (Martinus)</namePart></name><name><namePart>Duijn, van C.M. (Cock)</namePart></name><name><namePart>Swieten, van J.C.</namePart></name><name><namePart>Harskamp, van F. (Frans)</namePart></name><name><namePart>Koning, de I. (Inge)</namePart></name><name><namePart>Cruts, M. (Marc)</namePart></name><name><namePart>Jonghe, de C. (Chris)</namePart></name><name><namePart>Kumar-Singh, S. (Samir)</namePart></name><name><namePart>Tibben, A. (Arend)</namePart></name><name><namePart>Broeckhoven, van C. (Christine)</namePart></name><name><namePart>Hofman, A. (Albert)</namePart></name><subject lang="nl"><topic>Male</topic><topic>Adult</topic><topic>Female</topic><topic>Humans</topic><topic>Middle aged</topic><topic>Research Support, Non-U.S. Gov&apos;t</topic><topic>Pedigree</topic><topic>Genetic Predisposition to Disease</topic><topic>Age of Onset</topic><topic>Family Health</topic><topic>Neuropsychological Tests</topic><topic>*Heterozygote</topic><topic>*Mutation, Missense</topic><topic>Alzheimer Disease/*genetics/pathology</topic><topic>Amyloid beta-Protein Precursor/*genetics</topic><topic>Amyloidosis/*genetics/pathology</topic></subject><accessCondition></accessCondition><location><url>http://hdl.handle.net/1765/9469</url></location><language><languageTerm type="text">en</languageTerm></language><genre authority="local">journalArticle</genre><identifier type="issn">0006-8950</identifier><abstract>Several mutations in the amyloid precursor protein (APP) gene may lead to
      either Alzheimer&apos;s disease or cerebral haemorrhage due to congophilic
      amyloid angiopathy (CAA). A single family is known in which both types of
      pathology are expressed because of a missense mutation at codon 692 of the
      APP gene (APP692). Here we describe the clinical and pathological
      expression of APP692 in eight patients with the mutation. Furthermore, 21
      first-degree relatives with an a priori risk of 50% of being a carrier
      were tested for the APP692 mutation and studied for presymptomatic signs
      by neurological examination, neuropsychological testing and brain MRI.
      Patients with APP692 presented with haemorrhage, dementia or both. The
      dementia in patients with the APP692 mutation was compatible with
      Alzheimer&apos;s disease both clinically and neuropathologically. Of the 21
      healthy relatives at 50% risk, five carried the APP692 mutation. The
      presymptomatic carriers showed a subtle, non-significant impairment of
      cognitive function compared with relatives without APP692. A significant
      increase in the number of periventricular and subcortical white matter
      lesions at young age was seen in presymptomatic carriers (mean age 26.4
      years). The findings of this study suggest that a single (genetic)
      mechanism may underlie the pathology of Alzheimer&apos;s disease and CAA. These
      diseases are manifested subclinically by white matter pathology. Further
      insight into the relationship between CAA and Alzheimer&apos;s disease may
      provide clues about the aetiology of Alzheimer&apos;s disease.</abstract><relatedItem type="host"><titleInfo><title>Brain: a journal of neurology</title></titleInfo><originInfo><dateIssued>2000-01-01</dateIssued>
</originInfo><identifier type="issn">0006-8950</identifier>
<identifier type="doi">urn:NBN:nl:ui:15-1765/9469</identifier>
<part><extent unit="page"></extent></part></relatedItem></mods>
